Powell đã tham dự sự kiện của Ban Tài chính Quốc tế của Fed: tưởng nhớ Fischer, nhắc lại tầm quan trọng của nghiên cứu kinh tế toàn cầu và không thảo luận về triển vọng chính sách

Lamellar Biomedical

company

About

Lamellar Biomedical develops novel healthcare products based on the mimicry or modification of the lamellar body secretory system.

  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
£2.33M
Industries
Biotechnology,Health Care,Medical Device
Founded date
Jun 1, 2007
Number Of Employee
11 - 50
Operating Status
Active

Lamellar Biomedical Ltd was established in June 2007 when the founding Directors of the Company, recognising the considerable therapeutic potential of Lamellasomes™, acquired the intellectual property rights to the technology.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
£11.38M
Lamellar Biomedical has raised a total of £11.38M in funding over 2 rounds. Their latest funding was raised on May 8, 2017 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 8, 2017 Series C £5.75M 1 Invesco Detail
Jul 24, 2015 Series Unknown £2.33M 2 Detail
Jan 7, 2013 Series A £3.30M 2 Invesco Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Lamellar Biomedical is funded by 2 investors. Invesco and Barwell Plc are the most recent investors.
Investor Name Lead Investor Funding Round
Invesco Yes Series C
Barwell Plc Series Unknown